The company reported Mr. Rodriguez’s compensation at $73.4 million as of June 2021, which includes a five year equity grant. The equity grant is not guaranteed, but based on meeting specific benchmarks over time. The report calculated Mr. Rodriguez’s CEO-to-worker pay ratio of 1,137-1. The DaVita network serves patients at 2,815 outpatient dialysis centers, in homes and in hospitals. It operates 339 outpatient dialysis centers in 10 countries worldwide.
Mr. Rodriguez took the helm in 2019 and last year grew the company to $978 million in net income, up from $774 million in 2020.
The only CEO ahead of Mr. Rodriguez on the list was Leonard Schleifer, MD, PhD, CEO of Regeneron Pharmaceuticals. Dr. Schleifer made $121.7 million with a CEO-to-worker pay ratio of 933-1. Mr. Rodriguez was ahead of Johnson & Johnson CEO Alex Gorsky, Centene CEO Michael Neidorff and Walgreens Boots Alliance CEO Stefano Pessina.
Samuel Hazen, CEO of HCA Healthcare, also made the list with $30.4 million in pay and a CEO-to-worker pay ratio of 556-1.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.